Gates Package — page 191

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl Bill & Melinda Gates Foundation (BMGF), Foundation for the National Institutes of Health, 2010-0434 Gift 2/15/2012] 6/30/2017} Inc. (FNIH) Clifton Barry 2010-0443 CTA - Clinical Trial Agreement 8/20/2010) Adamas Pharmaceuticals, Inc. Richard Davey 2010-0488 Research Collaboration Agreement 2/26/2014] _7/27/2017|Medical Research Council (MRC) [GB] Patrick Duffy 2010-0612 CTA - Clinical Trial Agreement 1/26/2011 Genzyme (acq by Sanofi 2/16/2011) [US] David McDermott 2010-0612 CTA - Clinical Trial Agreement 1/26/2011 Genzyme (acq by Sanofi 2/16/2011) [US] David McDermott 2010-0639 CRADA 1/7/2011 1/7/2020] Amgen Inc. Ulrich Siebenlist 2010-0676 CTA - Clinical Trial Agreement 10/8/2010) Romark Laboratories, L.C. Shyamasundaran PaxVax, Inc. (aquired by Emergent BioSolutions 2010-0751 CRADA 12/12/2011] 12/12/2018|10/04/2018) Mark Connors 2010-0754 Gift 11/12/2010 National Psoriasis Foundation 2010-0754 Gift 11/12/2010} National Psoriasis Foundation 2010-0806 Gift 11/3/2010) Bill & Melinda Gates Foundation (BMGF) Harlan Caldwell 2011-0072 Research Collaboration Agreement 6/21/2010) Netherlands Cancer Institute (NKI) [NL] Jonathan (Jon) Ye 2011-0143 CTA - Clinical Trial Agreement 4/22/2011 NexBio, Inc. Richard Davey 2011-0290 CTA - Clinical Trial Agreement 10/6/2011 Pharmasset (bought by Gilead 11/2011) Shyamasundaran 2011-0381 CRADA 5/4/2015} 7/21/2017] Microbiotix, Inc. Sanjay Desai Jenner Institute [GB], University of Oxford (incl Isis 2011-0419 CTA - Clinical Trial Agreement 6/2/2011 Innovation, The Chancellor, Masters and Scholars I Ruth Ellis Walter Reed Army Institute of Research (WRAIR) 2011-0468 Research Collaboration Agreement 8/9/2011] 8/9/2024] (DoD) Walter Reed Army Institute of Research (WRAIR) 2011-0468 Research Collaboration Agreement 8/9/2011 8/9/2024] (DoD) Johns Hopkins Bloomberg School of Public Health (JHU), PATH (Program for Appropriate Technology 2011-0469 CTA - Clinical Trial Agreement 8/21/2012 in Health) Johns Hopkins Bloomberg School of Public Health (JHU), PATH (Program for Appropriate Technology 2011-0469 CTA - Clinical Trial Agreement 8/21/2012 in Health) Johns Hopkins Bloomberg School of Public Health (JHU), PATH (Program for Appropriate Technology 2011-0469 CTA - Clinical Trial Agreement 8/21/2012 in Health)